Literature DB >> 225008

Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis.

R J Risdall, R W McKenna, M E Nesbit, W Krivit, H H Balfour, R L Simmons, R D Brunning.   

Abstract

Nineteen patients whose bone marrow smears showed histiocytic hyperplasia with prominent hemophagocytosis were found to have a clinicopathologic syndrome associated with active viral infection. High fever, constitutional symptoms, liver function, and coagulation abnormalities and peripheral blood cytopenias were characteristic findings. Hepatosplenomegaly, lymphadenopathy, bilateral pulmonary infiltrates, and skin rash were often present. Fourteen of the patients were immunosuppressed. Active infection by herpes group viruses was documented in 14 patients and by adenovirus in 1. The bone marrow of most patients also showed decreased granulopoiesis and erythropoiesis with normal to increased numbers of megakaryocytes. Treatment generally consisted of supportive therapy and withdrawal of immunosuppressive drugs. Thirteen patients recovered. Lymph node biopsy and autopsy material showed generalized histiocytic hyperplasia with hemophagocytosis. The relationship of this disorder to familial hemophagocytic reticulosis, familial erythrophagocytic lymphohistiocytosis, histiocytic medullary reticulosis, and malignant histiocytosis is discussed. Immunosuppressive and cytotoxic therapy may be contraindicated in the treatment of this virus-associated syndrome.

Entities:  

Mesh:

Year:  1979        PMID: 225008     DOI: 10.1002/1097-0142(197909)44:3<993::aid-cncr2820440329>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  158 in total

1.  Autoimmune-associated haemophagocytic syndrome in a patient with rheumatoid arthritis.

Authors:  M Negishi; T Kasama; H Iwabuchi; H Kanemitsu; H Ide
Journal:  Clin Rheumatol       Date:  2002-02       Impact factor: 2.980

2.  CNS involvement of virus-associated hemophagocytic syndrome: MR imaging appearance.

Authors:  K P Forbes; D A Collie; A Parker
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

3.  Immature and transitional B cells are latency reservoirs for a gammaherpesvirus.

Authors:  Carrie B Coleman; Michael S Nealy; Scott A Tibbetts
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

4.  Dengue haemorrhagic fever: a risk of returning home.

Authors:  M G Jacobs; M G Brook; W R Weir; B A Bannister
Journal:  BMJ       Date:  1991-04-06

5.  A case of cytophagic histiocytic panniculitis: successful treatment of recurrent attacks with steroid pulse therapy and oral cyclosporin A.

Authors:  S Nakane; Y Kawabe; K Eguchi; A Kita; A Mizokami; H Yamasaki; S Nagataki
Journal:  Clin Rheumatol       Date:  1997-06       Impact factor: 2.980

6.  Hemophagocytic Lymphohistiocytosis Associated with Hepatitis A and Hepatitis E Co-infection.

Authors:  Sushil Kumar Choudhary; Anurag Agarwal; R N Mandal; Rajat Grover
Journal:  Indian J Pediatr       Date:  2016-01-29       Impact factor: 1.967

7.  Line-selective macrophage activation with an anti-CD40 antibody drives a hemophagocytic syndrome in mice.

Authors:  Giada Ingoglia; Ayla Yalamanoglu; Marc Pfefferlé; Irina L Dubach; Christian A Schaer; Kristyna Valkova; Kerstin Hansen; Nadja Schulthess; Rok Humar; Dominik J Schaer; Florence Vallelian
Journal:  Blood Adv       Date:  2020-06-23

8.  Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.

Authors:  J D Lay; C J Tsao; J Y Chen; M E Kadin; I J Su
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

9.  Peripheral T cell lymphoma-associated hemophagocytic syndrome in a patient with human adjuvant disease.

Authors:  Masao Negishi; Tsuyoshi Kasama; Ryosuke Hanaoka; Hirotsugu Ide; Shigeko Inokuma
Journal:  Rheumatol Int       Date:  2003-02-06       Impact factor: 2.631

10.  [Development of the risk of infection in the child with leukemia].

Authors:  P Lutz; G Delage; G E Rivard; G Berdnikoff
Journal:  Can Med Assoc J       Date:  1983-09-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.